As of April 08, 2026, Martin and Harris Laboratories, Unlisted Shares are trading at ₹920.00 per share and face value is ₹10.00/share, with a 52-week high of ₹920.00 and 52-week low of ₹840.00. The minimun lot size is 220 shares, and the shares are traded on NSDL.
ISIN
INE03VV01015
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
39,96,040
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
367.64 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Profit After Tax
40.43 Cr
It is the final profit left over after subtracting all operating and non operating items from net revenue.
Total Revenue
146.15 Cr
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
P/E
9.09
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
P/B
0.66
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Micro Cap
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
19.57 Cr
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
About Martin & Harris
Established in 1993,Martin and Harris Labs Ltd. is a vertically integrated biopharmaceutical laboratory offering expertise in Drug Development and Pharmaceutical Manufacturing. A team of competent scientists providing innovative solutions for drug development, along with state-of-the-art manufacturing facilities work passionately towards providing high quality end products and services to ensure complete customer satisfaction.
The company has extensive manufacturing plants in Roorkee and Gagreth which have been built in accordance with the WHO GMP guidelines and these have separate quality control units and quality assurance functions to monitor the manufacturing quality of their products.
Martin and Harris Laboratories Ltd. operates state-of-the-art manufacturing facilities located at prime locations of the country in order to serve their domestic & International markets. These units have a multi-decade experience of manufacturing different complex dosage forms and specialty formulations
Pharmaceutical, medical, chemical, and botanical product manufacture are the main activities of Martin & Harris Laboratories Ltd.
In addition to its primary pharmaceutical business, it manages its money by investing in various opportunities that yield strong returns, such as mutual funds, listed and unlisted stocks, etc. Delite Infrastructure Limited, an investment arm of Martin & Harris, handles all the related operations.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.